Samuel Callisto, PhD

Samuel Callisto, PhD has a diverse work experience in the field of pharmaceutical research and academia. Samuel is currently employed as a Senior Scientist at Metrum Research Group since January 2023. Previously, they worked as a Research Scientist at the same company from April 2019 to January 2023.

In addition to their industry experience, Samuel also holds an academic position as an Adjunct Assistant Professor at the University of Minnesota College of Pharmacy, starting from July 2020.

During their time at the University of Minnesota, Samuel worked as a PhD Candidate from September 2014 to April 2019, specializing in neuropharmacology of antiepileptic drugs. Samuel conducted extensive research under the guidance of Dr. Susan Marino and Dr. Angela Birnbaum.

Furthermore, Samuel has gained valuable experience through various internships. Samuel served as a Development Design Center Graduate Intern at AbbVie in 2017, where their responsibilities included modeling and simulation of clinical trial designs. Samuel also worked as a Graduate Intern at OneOme in 2016, contributing to validation studies for RightMed pharmacogenomic test and preparing regulatory documents.

Before pursuing their PhD, Samuel worked as a Junior Scientist at the University of Minnesota-Twin Cities from July 2012 to August 2014, focusing on HIV research and providing technical support for the lab. Samuel also worked as a Personal Biology Tutor at Saint Mary's University of Minnesota from 2011 to 2012.

Overall, Samuel Callisto, PhD has acquired a wealth of experience in pharmaceutical research, academia, and scientific support throughout their career.

Samuel Callisto, PhD, holds a Doctor of Philosophy (PhD) degree from the University of Minnesota College of Pharmacy, specializing in Experimental and Clinical Pharmacology. Samuel pursued their PhD from 2014 to 2019. Prior to that, they completed their Bachelor of Arts (BA) degree in Biology, General, from Saint Mary's University of Minnesota, which they obtained between 2008 and 2012.